Trial Condition(s):

Secondary prevention, Stroke, Ischemic heart disease, Coronary heart disease

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN) (EPISAT)

Bayer Identifier:

18116

ClinicalTrials.gov Identifier:

NCT02550717

EudraCT Number:

Not Available

EU CT Number:

Not Available

Study Completed

Trial Purpose

To investigate the risk of major bleeding (including gastrointestinal and intracranial bleeding episodes) among new users of low-dose acetylsalicylic acid (ASA) in clinical practice

Inclusion Criteria
-  Aged 40-84 years
 - Enrolled with the Primary Care Physician (PCP) for at least 2 years,
 - To have a history of computerized prescriptions for at least 1 year prior
 - To have at least one encounter/visit recorded in the last three years
Exclusion Criteria
- To be exposed to low dose ASA before entering in the study
 - Having a diagnosis of cancer before entering in the study
 - Having a diagnosis of alcohol abuse before entering in the study
 - Having a diagnosis of coagulopathies before entering in the study
 - Having a diagnosis of esophageal varices before entering in the study
 - Having a diagnosis of chronic liver disease before entering in the study

Trial Summary

Enrollment Goal
398158
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Aspirin (Acetylsalicylic Acid, BAYE4465)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Loactions, United Kingdom

Status
Completed

Trial Design